➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Merck
Baxter
Dow

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

EMGEL Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Emgel, and what generic alternatives are available?

Emgel is a drug marketed by Altana and is included in one NDA.

The generic ingredient in EMGEL is erythromycin. There are one hundred and three drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the erythromycin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Emgel

A generic version of EMGEL was approved as erythromycin by TORRENT on July 6th, 2020.

  Try it Free

US Patents and Regulatory Information for EMGEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Altana EMGEL erythromycin GEL;TOPICAL 063107-001 Aug 23, 1991 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Merck
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.